This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

edited by R.C. Griggs and G. Karpati, 316 pp, with illus, $79.50, New York, NY, Plenum Press, 1990.

Jack E. Riggs, MD, Reviewer
Morgantown, WVa

Arch Neurol. 1991;48(9):899.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Myoblast transfer represents an early exploitation in a therapeutic venture based on the tremendous advances made by molecular genetics. The possibility and promise of myoblast transfer therapy in the treatment of Duchenne muscular dystrophy and other inherited forms of muscle disease has raised the hopes and expectations of the public and, especially, affected individuals and their families.

This volume, a compilation of 35 presentations made at the International Conference on Myoblast Transfer Therapy in June 1989, is conveniently organized into seven general-topic sections relevant to myoblast therapy. The individual articles, which are well-written, short, and focused, present a realistic assessment of the challenges that will need to be addressed and mastered before myoblast transfer therapy can ever become "standard therapy." The discussions that follow individual articles and each general-topic section are very enlightening as they highlight many of the practical concerns and unresolved questions regarding myoblast transfer therapy.

The reader . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?